XEBIO Holdings CO., LTD. (8281) AI Stock Analysis

• Market Cap: ¥49.83B
• Dividend Yield: 2.92%
• Average Volume (3M): 71.25K
• Price to Earnings (P/E): 50.9
• Beta (1Y): 0.28
• Revenue Growth: 1.82%
• EPS Growth: -148.67%
• Country: JP
• Employees: 2,560
• Sector: Consumer Cyclical
• Sector Strength: 83
• Industry: Specialty Retail
• EPS (TTM): 6.96
• Shares Outstanding: 47,911,022
• 10 Day Avg. Volume: 65,700
• 30 Day Avg. Volume: 71,250
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,216.00
• Price Target Upside: 5.92% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 64 Neutral
• Price Target: ¥1,216.00 ▲(5.92% Upside)

XEBIO Holdings' overall score is driven by strong financial performance, particularly in revenue growth and balance sheet strength. Technical analysis indicates stability but with bearish momentum. Valuation is mixed due to a negative P/E ratio but is supported by a decent dividend yield.

XEBIO Holdings CO., LTD. Business Overview & Revenue Model

Company Description

XEBIO Holdings Co., Ltd. is a Japan-based company primarily engaged in the retail of sporting goods. The company operates through its subsidiaries and is involved in the planning, development, and sale of sports equipment, clothing, footwear, and accessories. It caters to a broad range of sports enthusiasts and provides products for numerous sports categories, such as golf, soccer, baseball, and outdoor activities. XEBIO Holdings is known for its extensive network of retail stores across Japan and its commitment to promoting a healthy and active lifestyle through its offerings.

How the Company Makes Money

XEBIO Holdings Co., Ltd. generates revenue primarily through the sale of sporting goods and related products in its retail stores. The company operates a chain of retail outlets across Japan, where it sells a wide variety of products, including sports equipment, apparel, and footwear. Revenue streams are bolstered by strategic partnerships with popular sports brands and exclusive distribution agreements, enabling the company to offer unique and desirable products to its customers. Additionally, XEBIO Holdings may engage in promotional activities and events to drive foot traffic and sales. The company's revenue is also supported by its online sales platform, which extends its reach beyond physical retail locations.

XEBIO Holdings CO., LTD. Financial Statement Overview

Summary

XEBIO Holdings demonstrates solid financial performance with consistent revenue growth and healthy gross margins. The balance sheet is strong with low leverage and substantial equity financing. Cash flow improvements are notable, though capital expenditures impact free cash flow ratios.

Income Statement

XEBIO Holdings has shown consistent revenue growth with a 3.37% increase in the latest year. Gross and net profit margins are healthy at 36.8% and 0.39% respectively, though the latter indicates some room for improvement in profitability. EBIT and EBITDA margins are at 2.8% and 3.64%, showing moderate operational efficiency.

Balance Sheet

The company maintains a strong financial position with a Debt-to-Equity ratio of 0.06, suggesting low leverage. A Return on Equity (ROE) of 0.8% highlights potential for increased profitability. The equity ratio stands at 59.7%, indicating substantial equity financing, which is favorable.

Cash Flow

XEBIO Holdings has demonstrated significant improvement in free cash flow, transitioning from negative to positive, signifying better cash management. The operating cash flow to net income ratio is strong at 12.42, reflecting robust cash generation relative to net income, though free cash flow to net income is lower, indicating CAPEX impacts.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	250.60B	250.60B	242.43B	239.29B	223.28B	202.44B
Gross Profit	97.67B	92.23B	92.89B	91.77B	87.05B	78.82B
EBITDA	8.39B	9.11B	9.72B	12.97B	9.25B	7.68B
Net Income	971.00M	971.00M	2.59B	5.40B	3.84B	412.00M
Balance Sheet
Total Assets	203.96B	203.96B	209.53B	211.30B	208.31B	207.48B
Cash, Cash Equivalents and Short-Term Investments	19.86B	19.86B	24.94B	32.89B	39.89B	44.32B
Total Debt	7.37B	7.37B	9.95B	12.63B	15.18B	15.43B
Total Liabilities	81.83B	81.83B	84.72B	88.73B	89.60B	91.13B
Stockholders Equity	121.72B	121.72B	124.45B	122.36B	118.66B	116.31B
Cash Flow
Free Cash Flow	0.00	5.31B	-2.86B	1.38B	-2.78B	20.13B
Operating Cash Flow	0.00	12.06B	4.27B	7.02B	2.23B	25.37B
Investing Cash Flow	0.00	-9.60B	-8.04B	-5.48B	-5.16B	-2.02B
Financing Cash Flow	0.00	-7.53B	-4.14B	-7.91B	-2.12B	8.51B

XEBIO Holdings CO., LTD. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1148.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8281, the sentiment is Positive. The current price of 1148 is above the 20-day moving average (MA) of 1135.65, above the 50-day MA of 1121.98, and below the 200-day MA of 1169.55, indicating a neutral trend. The MACD of 0.84 indicates Positive momentum. The RSI at 58.62 is Neutral, neither overbought nor oversold. The STOCH value of 62.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:8281.

XEBIO Holdings CO., LTD. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8281	64 Neutral	¥49.83B	50.89		2.92%	1.82%	-148.67%
Sector *	61 Neutral	$17.96B	13.14	-5.29%	3.00%	1.25%	-13.95%
ASKLF	―	$980.57M	15.21	11.66%	―	―	―
AB6	―	€715.38M	12.16	7.64%	―	―	―
7419	81 Outperform	¥347.93B	9.03		1.20%	14.62%	68.11%
8282	71 Outperform	¥250.53B	22.81		2.83%	2.42%	55.63%
7545	69 Neutral	¥132.81B	15.91		1.42%	4.06%	-2.33%

XEBIO Holdings CO., LTD. Corporate Events

XEBIO Holdings Reports Decline in Q1 2025 Financial Performance

XEBIO Holdings reported a decline in financial performance for the three months ending June 30, 2025, with net sales decreasing by 1.3% and profit attributable to owners of the parent plummeting by 89.6% compared to the same period last year. The company forecasts a modest recovery in net sales and operating profit for the fiscal year ending March 31, 2026, despite the challenging financial results in the first quarter.

XEBIO Holdings Finalizes Stock Option Issuance Terms

XEBIO Holdings Co., Ltd. has announced the finalization of terms for issuing stock acquisition rights as stock options, which were resolved at a recent Board of Directors meeting. This move involves the allocation of 2,500 stock acquisition rights to directors, executive officers, and employees, potentially impacting the company’s equity structure and providing incentives for key personnel.

XEBIO HOLDINGS Issues Stock Options to Boost Performance

XEBIO HOLDINGS CO., LTD. announced the issuance of stock acquisition rights as stock options to incentivize directors, executive officers, and employees. This move is intended to enhance the company’s business performance and align management priorities with shareholder interests. The issuance involves 250,000 common shares and 2,500 stock acquisition rights, with adjustments possible in case of stock splits or other corporate actions.

XEBIO Completes Arena Renovation and Donation to Sendai City

XEBIO Holdings CO., LTD. has completed the renovation and conditional donation of the ‘XEBIO Arena Sendai’ to Sendai City, finalizing an extraordinary loss of ¥2,370 million. The company will continue to manage the arena through its subsidiary under a 20-year management agreement, aiming to enhance regional contributions and community engagement through sports and cultural events.